Evidence map›Paper›PMID 39865814›Full record

ReviewMedicinal chemistry (Shariqah (United Arab Emirates))2025

Pyridine Derivatives: A Comprehensive Review of Their Potential as Anti-Diabetic Agents.

Deepak Dua, Prakash Kumar, Riya Anand, Salvi Sood, Gurdeep Singh

Abstract readReview
PubMed Publisher
In one paragraph

Review in Medicinal chemistry (Shariqah (United Arab Emirates)), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Deepak DuaDepartment of Pharmacy, School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, 14440, India.
Prakash KumarDepartment of Pharmacy, School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, 14440, India.
Riya AnandDepartment of Pharmacy, School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, 14440, India.
Salvi SoodDepartment of Pharmacy, School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, 14440, India.
Gurdeep SinghDepartment of Pharmacy, School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, 14440, India.ORCID 0000-0001-8789-9378

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDiabetes mellitus and obesity are two of the most frequent health conditions in the world, prompting medical researchers to seek novel effective treatments. According to World Health Organization (WHO) regulations and several research studies, diabetes is regarded as a significant and leading health concern worldwide. The search for efficient and safe antidiabetic drugs has led to the study of pyridine derivatives, a family of molecules with a wide range of pharmacological characteristics. Pyridines are important heterocyclic chemicals renowned for their various pharmacological properties.

methodsMaterials were compiled using the three databases of ScienceDirect, PubMed, and Google Scholar. For this study, only English-language publications have been evaluated based on their titles, abstracts, and full texts using keywords like diabetes, pyridine Derivatives, α- glucosidase inhibitors, and α-amylase inhibitors.

resultsPyridine and its derivatives have received a lot of attention due to their wide range of potential uses in medicinal chemistry and pharmacology. Structural alterations and optimization efforts have resulted in higher effectiveness, selectivity, and safety characteristics. These discoveries highlight the importance of pyridine analogues as a novel class of therapeutic agents for diabetes management.

conclusionThe review highlights the significance of pyridine analogues in the development of antidiabetic treatments, opening new avenues for developing drugs and clinical use. The ongoing advancements in the discovery of pyridine derivatives underscore their potential as prospective agents in diabetic treatments.

Indexed as

Diabetes MellitusHypoglycemic AgentsPyridinesAnimalsGlycoside Hydrolase InhibitorsHumansMolecular StructureGlycoside Hydrolase InhibitorsHypoglycemic AgentsPyridinesAnti-diabeticdiabetes mellituspyridinepyridine derivativesα-amylase inhibitors.α-glucosidase inhibitors

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.